In vivo evaluation of two types of bioactive scaffold used for tendon-bone interface healing in the reconstruction of anterior cruciate ligament

Biotechnol Lett. 2011 Apr;33(4):837-44. doi: 10.1007/s10529-010-0490-7. Epub 2010 Dec 7.

Abstract

Fibrin glue combined with bone morphogenetic protein (BMP) and recombined bone xenograft (RBX), were compared to evaluate their effect on the tendon-bone interface healing. The interface of fibrin glue-BMP developed new cartilage but the new bone was thinner whereas the interface of RBX had large areas of chondrocyte-like cells, bone formation and an immature neo-enthesis structure. At 12 weeks, bone mineral density of RBX group (152 ± 52 cm(3)) and fibrin glue-BMP group (109 ± 13 cm(3)) was calculated by micro-computed tomography. The ultimate load of fibrin glue-BMP group (60 ± 18 and 51 ± 14 N) and RBX group (65 ± 21 and 57 ± 15 N) was shown by biomechanics at 6 and 12 weeks. RBX thus has an advantage on accelerating tendon-bone interface healing.

MeSH terms

  • Animals
  • Anterior Cruciate Ligament* / growth & development
  • Anterior Cruciate Ligament* / surgery
  • Biomechanical Phenomena
  • Bone Morphogenetic Proteins / metabolism
  • Bone Morphogenetic Proteins / ultrastructure
  • Bone and Bones / metabolism*
  • Fibrin Tissue Adhesive / chemistry
  • Plastic Surgery Procedures
  • Rabbits
  • Tendons / metabolism*
  • Tissue Scaffolds / standards*
  • Wound Healing*

Substances

  • Bone Morphogenetic Proteins
  • Fibrin Tissue Adhesive